Could cholesterol remnants predict long-term cardiovascular events after NSTACS?

Abstract Introduction The remnant cholesterol (RC) promotes atherosclerotic cardiovascular disease. However, the prognostic impact of elevated RC levels in patients with non-ST-elevation acute coronary syndrome have not been established current population. Then, our objetive is investigated effect terms long-term mortality admitted for NSTACS Methods This an observational study which we included all discharged from cardiology ACS two centers 2003 to 2018. Patients were classified by low values <23 mg/dL or high ≥24 first blood count performed during hospitalization. We analyzed (continuous variable) on all-cause mortality, and MACE using Cox regression model adjusted several confounding variables. Results 5685 diagnosed ACS, a mean age 66.50 (SD ±13.20) years, 27.1% female. baseline, admission discharge characteristics are shown table (1 2). During follow-up (median 56 months, IQR 21–79 months) there was increased risk higher os unadjusted factors (age, sex, GRACE, early coronariography, hypertension, treatment at discharge), HR (1.003, CI 1.000–1.005, p 0.003). Similar results observed (HR 1.003, 1.000–1.006, 0.003), 1.002, 1.000–1.003, 0.002) Conclusion could follow up NSTACS, even after adjusting evidence-based treatments. There should be taken under consideration management patients. Funding Acknowledgement Type funding sources: None.